 Home > Active Ingredient News > Antitumor Therapy > ANN NEUROL: Cancer patients have higher blood coagulation markers and are susceptible to ischemic stroke

ANN NEUROL: Cancer patients have higher blood coagulation markers and are susceptible to ischemic stroke

 Last Update: 2021-11-12
 Source: Internet
 Author: User

Tags

makeup cause cancer

simple model

nair use

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

It is estimated that 4-20% of patients with ischemic stroke have cancer, and the comorbidity rate of these diseases is increasing
.
This may be due to recent improvements in cancer treatment that have prolonged the survival of patients

It is estimated that 4-20% of patients with ischemic stroke have cancer, and the comorbidity rate of these diseases is increasing
.

In order to improve the understanding of the mechanism of ischemic stroke in cancer patients, Babak Navi Babak Navi and others conducted a prospective study on the mechanism of ischemic stroke in cancer patients (most cancers), comparing active cancer patients with ischemic stroke and simple ischemic stroke Pre-designated hematological markers of coagulation, platelet and endothelial activation, and embolic disease between stroke patients and patients with simple active cancer.

This study explored the pathophysiological characteristics of ischemic stroke combined with cancer

From 2016 to 2020 , the research team conducted a prospective cross-sectional study in two hospitals
.

The levels of all studied biomarkers differed among the groups

The levels of all studied biomarkers differed among the groups
.

The study found that compared with the control group, patients with active cancer and acute ischemic stroke had higher coagulation, platelet and endothelial cell activation markers, and more circulating microemboli

Future research should evaluate whether these biomarkers can predict the risk of stroke and recurrence in cancer patients and the response to antithrombotic therapy

Original source

Mechanisms of Ischemic Stroke in Patients with Cancer: A Prospective Study.

Ann Neurol.

Mechanisms of Ischemic Stroke in Patients with Cancer: A Prospective Study.
Ann Neurol.
2021;90(1):159-169.
Leave a message here

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

1-(2-chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane 53-19-0

CAS No.: 53-19-0

Pharmacy Grade

$100/KG EXW

High Quality Resveratrol 99% powder 501-36-0 Shaanxi Dideu Medichem Co.Ltd

CAS No.: 501-36-0

Chemical Grade

$1/KG FOB

High purity Epirubicin hydrochloride 98% with best price 56390-09-1 and Epirubicin hydrochloride raw powder

CAS No.: 56390-09-1

Pharmacy Grade

$8.8-10/MT FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.